These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27237620)

  • 41. A Novel Relative High-Density Lipoprotein Index to Predict the Structural Changes in High-Density Lipoprotein and Its Ability to Inhibit Endothelial-Mesenchymal Transition.
    Lin FY; Lin YW; Shih CM; Lin SJ; Tung YT; Li CY; Chen YH; Lin CY; Tsai YT; Huang CY
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury.
    Brulhart-Meynet MC; Braunersreuther V; Brinck J; Montecucco F; Prost JC; Thomas A; Galan K; Pelli G; Pedretti S; Vuilleumier N; Mach F; Lecour S; James RW; Frias MA
    PLoS One; 2015; 10(3):e0119664. PubMed ID: 25781943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineered rHDL Nanoparticles as a Suitable Platform for Theranostic Applications.
    Aranda-Lara L; Isaac-Olivé K; Ocampo-García B; Ferro-Flores G; González-Romero C; Mercado-López A; García-Marín R; Santos-Cuevas C; Estrada JA; Morales-Avila E
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of reconstituted high-density lipoprotein particles formed by lipid interactions with human serum amyloid A.
    Takase H; Furuchi H; Tanaka M; Yamada T; Matoba K; Iwasaki K; Kawakami T; Mukai T
    Biochim Biophys Acta; 2014 Oct; 1842(10):1467-74. PubMed ID: 25063355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.
    Kar S; Patel MA; Tripathy RK; Bajaj P; Suvarnakar UV; Pande AH
    Biochim Biophys Acta; 2012 Sep; 1821(9):1200-10. PubMed ID: 22634518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions.
    Liu L; He H; Zhang M; Zhang S; Zhang W; Liu J
    Biomaterials; 2014 Sep; 35(27):8002-14. PubMed ID: 24947229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Simple Method to Extract Whole Apolipoproteins for the Preparation of Discoidal Recombined High Density Lipoproteins as Bionic Nanocarriers for Drug Delivery.
    Zhang W; Wang J; Jia J; Chen L; Wu Z; Liu J
    J Pharm Pharm Sci; 2015; 18(2):184-98. PubMed ID: 26158284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
    Sabnis S; Sabnis NA; Raut S; Lacko AG
    Int J Nanomedicine; 2017; 12():1453-1464. PubMed ID: 28260891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly.
    Quach D; Vitali C; La FM; Xiao AX; Millar JS; Tang C; Rader DJ; Phillips MC; Lyssenko NN
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1968-1979. PubMed ID: 27671775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1.
    Wu BJ; Chen K; Shrestha S; Ong KL; Barter PJ; Rye KA
    Circ Res; 2013 Jan; 112(2):278-88. PubMed ID: 23123430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A high-density lipoprotein-mediated drug delivery system.
    Mo ZC; Ren K; Liu X; Tang ZL; Yi GH
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):132-147. PubMed ID: 27208399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic applications of reconstituted HDL: When structure meets function.
    Darabi M; Guillas-Baudouin I; Le Goff W; Chapman MJ; Kontush A
    Pharmacol Ther; 2016 Jan; 157():28-42. PubMed ID: 26546991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.
    Duong M; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA
    Biochemistry; 2003 Nov; 42(46):13778-85. PubMed ID: 14622025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [
    Isaac-Olivé K; Ocampo-García BE; Aranda-Lara L; Santos-Cuevas CL; Jiménez-Mancilla NP; Luna-Gutiérrez MA; Medina LA; Nagarajan B; Sabnis N; Raut S; Prokai L; Lacko AG
    Nanoscale; 2019 Jan; 11(2):541-551. PubMed ID: 30543234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis.
    Ding Y; Wang Y; Zhou J; Gu X; Wang W; Liu C; Bao X; Wang C; Li Y; Zhang Q
    Biomaterials; 2014 Aug; 35(25):7214-27. PubMed ID: 24875759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of reconstituted discoidal high-density lipoproteins on lipid mobilization in RAW 264.7 and CHOK1 cells.
    Toledo JD; Cabaleiro LV; Garda HA; Gonzalez MC
    J Cell Biochem; 2012 Apr; 113(4):1208-16. PubMed ID: 22095661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.
    Ma X; Song Q; Gao X
    Acta Pharm Sin B; 2018 Jan; 8(1):51-63. PubMed ID: 29872622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrasound-Stimulated Drug Delivery Using Therapeutic Reconstituted High-Density Lipoprotein Nanoparticles.
    Xiong F; Nirupama S; Sirsi SR; Lacko A; Hoyt K
    Nanotheranostics; 2017; 1(4):440-449. PubMed ID: 29188177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.
    Pérez-Medina C; Tang J; Abdel-Atti D; Hogstad B; Merad M; Fisher EA; Fayad ZA; Lewis JS; Mulder WJ; Reiner T
    J Nucl Med; 2015 Aug; 56(8):1272-7. PubMed ID: 26112022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.
    Wang B; Yuan Y; Han L; Ye L; Shi X; Feng M
    J Drug Target; 2014 Jan; 22(1):76-85. PubMed ID: 24093636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.